Manuel Battegay
Suicide in HIV-Infected Individuals and the General Population in Switzerland, 1988-2008
Keiser O, Egger M, Bernasconi E, Schmid P, Battegay M, Christen A, Tissot F, Gayet-Ageron A, Hasse B, Brinkhof M, Spoerri A, for the Swiss HIV Cohort Study and the Swiss National Cohort. Suicide in HIV-Infected Individuals and the General Population in Switzerland, 1988-2008. The American journal of psychiatry 2009
15.12.2009Suicide in HIV-Infected Individuals and the General Population in Switzerland, 1988-2008
15.12.2009The American journal of psychiatry 2009
Keiser Olivia, Egger Matthias, Bernasconi Enos, Schmid Patrick, Battegay Manuel, Christen Anna, Tissot Frédéric, Gayet-Ageron Angèle, Hasse Barbara, Brinkhof Martin W G, Spoerri Adrian, for the Swiss HIV Cohort Study and the Swiss National Cohort
Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study
Rotger M, Tarr P, Telenti A, Ledergerber B, Weber R, Witteck A, Furrer H, Hirschel B, Battegay M, Bernasconi E, Cavassini M, Martinez R, Taffé P, Bayard C, Swiss HIV Cohort Study. Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study. Circulation. Cardiovascular genetics 2009; 2:621-8.
01.12.2009Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study
01.12.2009Circulation. Cardiovascular genetics 2009; 2:621-8
Rotger Margalida, Tarr Philip E, Telenti Amalio, Ledergerber Bruno, Weber Rainer, Witteck Andrea, Furrer Hansjakob, Hirschel Bernard, Battegay Manuel, Bernasconi Enos, Cavassini Matthias, Martinez Raquel, Taffé Patrick, Bayard Cornelia, Swiss HIV Cohort Study
Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy
Young J, Bucher H, Battegay M, Vernazza P, Tarr P, Hirschel B, Furrer H, Rickenbach M, Bernasconi E, Glass T, Swiss HIV Cohort Study. Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy. Journal of clinical epidemiology 2009; 62:632-41.
01.06.2009Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy
01.06.2009Journal of clinical epidemiology 2009; 62:632-41
Young Jim, Bucher Heiner C, Battegay Manuel, Vernazza Pietro, Tarr Philip E, Hirschel Bernard, Furrer Hansjakob, Rickenbach Martin, Bernasconi Enos, Glass Tracy R, Swiss HIV Cohort Study
Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study
Khanna N, Hirsch H, Battegay M, Bernasconi E, Vernazza P, Fux C, Cavassini M, Garzoni C, Mueller N, Elzi L, Swiss HIV Cohort Study. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:1459-66.
15.05.2009Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study
15.05.2009Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:1459-66
Khanna Nina, Hirsch Hans H, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Fux Christoph A, Cavassini Matthias, Garzoni Christian, Mueller Nicolas J, Elzi Luigia, Swiss HIV Cohort Study
JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy
Khanna N, Hirsch H, Battegay M, Viscidi R, Bernasconi E, Vernazza P, Fux C, Du Pasquier R, Garzoni C, Mueller N, Wolbers M, Swiss HIV Cohort Study. JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy. Journal of virology 2009; 83:4404-11.
01.05.2009JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy
01.05.2009Journal of virology 2009; 83:4404-11
Khanna Nina, Hirsch Hans H, Battegay Manuel, Viscidi Raphael, Bernasconi Enos, Vernazza Pietro, Fux Christoph A, Du Pasquier Renaud A, Garzoni Christian, Mueller Nicolas J, Wolbers Marcel, Swiss HIV Cohort Study
Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland
von Wyl V, Günthard H, Ledergerber B, Bonhoeffer S, Francioli P, Vernazza P, Hirschel B, Furrer H, Cavassini M, Bernasconi E, Battegay M, Klimkait T, Bürgisser P, Yerly S, Swiss HIV Cohort Study. Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:979-87.
01.04.2009Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland
01.04.2009Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:979-87
von Wyl Viktor, Günthard Huldrych F, Ledergerber Bruno, Bonhoeffer Sebastian, Francioli Patrick, Vernazza Pietro, Hirschel Bernard, Furrer Hansjakob, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Klimkait Thomas, Bürgisser Philippe, Yerly Sabine, Swiss HIV Cohort Study
Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study
Conen A, Battegay M, Bucher H, Bernasconi E, Cavassini M, Hirschel B, Vernazza P, Weber R, Furrer H, Glass T, Fehr J, Swiss HIV Cohort Study. Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study. Antiviral therapy 2009; 14:349-57.
01.01.2009Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study
01.01.2009Antiviral therapy 2009; 14:349-57
Conen Anna, Battegay Manuel, Bucher Heiner C, Bernasconi Enos, Cavassini Matthias, Hirschel Bernard, Vernazza Pietro, Weber Rainer, Furrer Hansjakob, Glass Tracy R, Fehr Jan, Swiss HIV Cohort Study
Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals
Elzi L, Battegay M, Bernasconi E, Vernazza P, Hirschel B, Cavassini M, Fux C, Weber R, Kaufmann G, Swiss HIV Cohort Study. Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals. HIV clinical trials 2009; 10:207-14.
01.01.2009Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals
01.01.2009HIV clinical trials 2009; 10:207-14
Elzi Luigia, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Hirschel Bernard, Cavassini Matthias, Fux Christoph A, Weber Rainer, Kaufmann Gilbert, Swiss HIV Cohort Study
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV
Young J, Battegay M, Bernasconi E, Vernazza P, Cavassini M, Hirschel B, Fux C, Rickenbach M, Guenthard H, Bucher H, Swiss HIV Cohort Study. Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV. Antiviral therapy 2009; 14:771-9.
01.01.2009Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV
01.01.2009Antiviral therapy 2009; 14:771-9
Young Jim, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Hirschel Bernard, Fux Christoph A, Rickenbach Martin, Guenthard Huldrych F, Bucher Heiner C, Swiss HIV Cohort Study
Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007
Ballif M, Weber R, Opravil M, Rickenbach M, Furrer H, Hirschel B, Schmid P, Bernasconi E, Cavassini M, Battegay M, Ledergerber B, Swiss HIV Cohort Study. Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007. PloS one 2009; 4:e8275.
01.01.2009Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007
01.01.2009PloS one 2009; 4:e8275
Ballif Marie, Weber Rainer, Opravil Milos, Rickenbach Martin, Furrer Hansjakob, Hirschel Bernard, Schmid Patrick, Bernasconi Enos, Cavassini Matthias, Battegay Manuel, Ledergerber Bruno, Swiss HIV Cohort Study
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy
Khanna N, Kaufmann G, Battegay M, Hirschel B, Weber R, Bernasconi E, Vernazza P, Cavassini M, Furrer H, Opravil M, Swiss HIV Cohort Study. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 47:1093-101.
15.10.2008CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy
15.10.2008Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 47:1093-101
Khanna Nina, Kaufmann Gilbert R, Battegay Manuel, Hirschel Bernard, Weber Rainer, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Furrer Hansjakob, Opravil Milos, Swiss HIV Cohort Study
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication
Ciuffreda D, Bernasconi E, Monnat M, Cerny A, Chuard C, Borovicka J, Mentha G, Pascual M, Gonvers J, Pantaleo G, Oneta C, Malinverni R, Comte D, Cavassini M, Giostra E, Buhler L, Perruchoud M, Heim M, Battegay M, Genné D, Mulhaupt B, Dutoit V. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. European journal of immunology 2008; 38:2665-77.
01.10.2008Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication
01.10.2008European journal of immunology 2008; 38:2665-77
Ciuffreda Donatella, Bernasconi Enos, Monnat Martine, Cerny Andreas, Chuard Christian, Borovicka Jan, Mentha Gilles, Pascual Manuel, Gonvers Jean-Jacques, Pantaleo Giuseppe, Oneta Carl, Malinverni Raffaele, Comte Denis, Cavassini Matthias, Giostra Emiliano, Buhler Leo, Perruchoud Monika, Heim Markus H, Battegay Manuel, Genné Daniel, Mulhaupt Beat, Dutoit Valérie
Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study
Vo T, Weber R, Vernazza P, Bernasconi E, Cavassini M, Battegay M, Furrer H, Hirschel B, Keiser O, Ledergerber B, Swiss HIV Cohort Study. Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study. The Journal of infectious diseases 2008; 197:1685-94.
15.06.2008Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study
15.06.2008The Journal of infectious diseases 2008; 197:1685-94
Vo Thi Tuyet Nhung, Weber Rainer, Vernazza Pietro, Bernasconi Enos, Cavassini Matthias, Battegay Manuel, Furrer Hansjakob, Hirschel Bernard, Keiser Olivia, Ledergerber Bruno, Swiss HIV Cohort Study
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir
von Wyl V, Günthard H, Ledergerber B, Rickenbach M, Vernazza P, Hirschel B, Furrer H, Cavassini M, Bernasconi E, Battegay M, Klimkait T, Bürgisser P, Böni J, Yerly S, Swiss HIV Cohort Study. Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 46:1299-309.
15.04.2008Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir
15.04.2008Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008; 46:1299-309
von Wyl Viktor, Günthard Huldrych F, Ledergerber Bruno, Rickenbach Martin, Vernazza Pietro, Hirschel Bernard, Furrer Hansjakob, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Klimkait Thomas, Bürgisser Philippe, Böni Jürg, Yerly Sabine, Swiss HIV Cohort Study
Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons
Berger S, Weber R, Battegay M, Ledergerber B, Vernazza P, Regli D, Furrer H, Zellweger C, Ehlert U, von Wyl V, Schad T, Gaab J. Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons. AIDS (London, England) 2008; 22:767-75.
30.03.2008Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons
30.03.2008AIDS (London, England) 2008; 22:767-75
Berger Simona, Weber Rainer, Battegay Manuel, Ledergerber Bruno, Vernazza Pietro, Regli Daniel, Furrer Hansjakob, Zellweger Claudine, Ehlert Ulrike, von Wyl Viktor, Schad Tanja, Gaab Jens
Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy
Polesel J, Franceschi S, Schmid P, Probst-Hensch N, Levi F, Hasse B, Furrer H, Bouchardy C, Battegay M, Dal Maso L, Rickenbach M, Clifford G, Swiss HIV Cohort Study. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS (London, England) 2008; 22:301-6.
11.01.2008Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy
11.01.2008AIDS (London, England) 2008; 22:301-6
Polesel Jerry, Franceschi Silvia, Schmid Patrick, Probst-Hensch Nicole M, Levi Fabio, Hasse Barbara, Furrer Hansjakob, Bouchardy Christine, Battegay Manuel, Dal Maso Luigino, Rickenbach Martin, Clifford Gary M, Swiss HIV Cohort Study
Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients
Glass T, Bucher H, Weber R, Rickenboch M, Bernasconi E, Vernazza P, Covassini M, Furrer H, Battegay M, Hirschel B, De Geest S, Swiss HIV Cohort Study. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antiviral therapy 2008; 13:77-85.
01.01.2008Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients
01.01.2008Antiviral therapy 2008; 13:77-85
Glass Tracy R, Bucher Heiner C, Weber Rainer, Rickenboch Martin, Bernasconi Enos, Vernazza Pietro, Covassini Matthias, Furrer Hansjakob, Battegay Manuel, Hirschel Bernard, De Geest Sabina, Swiss HIV Cohort Study
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study
Wolbers M, Bucher H, Günthard H, Yerly S, Battegay M, Bernasconi E, Vernazza P, Cavassini M, Furrer H, Hirschel B, von Wyl V, Opravil M, Swiss HIV Cohort Study. Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study. AIDS (London, England) 2007; 21:2201-7.
18.10.2007Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study
18.10.2007AIDS (London, England) 2007; 21:2201-7
Wolbers Marcel, Bucher Heiner C, Günthard Huldrych, Yerly Sabine, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Furrer Hansjakob, Hirschel Bernard, von Wyl Viktor, Opravil Milos, Swiss HIV Cohort Study
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types
von Wyl V, Günthard H, Ledergerber B, Perrin L, Rickenbach M, Bernasconi E, Vernazza P, Hirschel B, Telenti A, Furrer H, Battegay M, Klimkait T, Bürgisser P, Böni J, Yerly S, for the Swiss HIV Cohort Study. Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Archives of internal medicine 2007; 167:1782-90.
10.09.2007Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types
10.09.2007Archives of internal medicine 2007; 167:1782-90
von Wyl Viktor, Günthard Huldrych F, Ledergerber Bruno, Perrin Luc, Rickenbach Martin, Bernasconi Enos, Vernazza Pietro, Hirschel Bernard, Telenti Amalio, Furrer Hansjakob, Battegay Manuel, Klimkait Thomas, Bürgisser Philippe, Böni Jürg, Yerly Sabine, for the Swiss HIV Cohort Study
Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study
Glass T, Bucher H, Battegay M, Hirschel B, Cavassini M, Bernasconi E, Furrer H, Rickenbach M, Vernazza P, Weber R, Swiss HIV Cohort Study. Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study. HIV clinical trials 2007; 8:77-85.
01.03.2007Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study
01.03.2007HIV clinical trials 2007; 8:77-85
Glass Tracy R, Bucher Heiner C, Battegay Manuel, Hirschel Bernard, Cavassini Matthias, Bernasconi Enos, Furrer Hansjakob, Rickenbach Martin, Vernazza Pietro, Weber Rainer, Swiss HIV Cohort Study